David Szekeres
2020
Compensation breakdown
| Non-Equity Incentive Plan | $161,664 |
|---|---|
| Option Awards | $1,500,673 |
| Salary | $476,910 |
| Stock Awards | $314,400 |
| Other | $8,550 |
| Total | $2,462,197 |
Szekeres received $1.5M in option awards, accounting for 61% of the total pay in 2020.
Szekeres also received $161.7K in non-equity incentive plan, $476.9K in salary, $314.4K in stock awards and $8.6K in other compensation.
Rankings
In 2020, David Szekeres' compensation ranked 4,618th out of 13,090 executives tracked by ExecPay. In other words, Szekeres earned more than 64.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,618 out of 13,090 | 65th |
Division Manufacturing | 1,877 out of 5,621 | 67th |
Major group Chemicals And Allied Products | 732 out of 2,254 | 68th |
Industry group Drugs | 627 out of 1,954 | 68th |
Industry Pharmaceutical Preparations | 474 out of 1,459 | 68th |
Pay ratio
| David Szekeres' Pay | $2,462,197 |
|---|---|
| Median Employee's Pay | $363,920 |
| Pay Ratio | 7to 1 |
In 2020, the annual total compensation of David Szekeres was $2,462,197.
The annual total compensation of the median employee at Heron Therapeutics was $363,920.
The ratio of David Szekeres' pay to the pay of median employee was therefore 7 to one.
Szekeres' colleagues
We found five more compensation records of executives who worked with David Szekeres at Heron Therapeutics in 2020.
2020
Barry Quart
Heron Therapeutics
Chief Executive Officer
2020
John Poyhonen
Heron Therapeutics
President and Chief Commercial Officer
2020
Kimberly Manhard
Heron Therapeutics
Executive Vice President, Drug Development
2020
Lisa Peraza
Heron Therapeutics
Chief Accounting Officer
2020
Robert Hoffman
Heron Therapeutics
Chief Financial Officer
News
April 29, 2024
May 1, 2023
April 25, 2022
April 22, 2021